NIH-funded research R21 grant

Finding new ways to enhance radiation treatment for cervical cancer

Official title: Identifying Novel Radiation Sensitizers in Cervical Cancer

Funded at University of Tx Md Anderson Can Ctr · NIH-10977475 · Data updated 2026-11-12

This study is looking for ways to help women with cervical cancer by finding new treatments that work better with radiation therapy, using a gentle swab to collect tissue samples to see how their bodies respond to the treatment and identify any genetic changes that could help predict their response.

More Cervical Cancer research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startDecember 7, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$60,596
NIH project number3R21CA277332-02S1
Project IDNIH-10977475 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with cervical cancer who are undergoing chemoradiation treatment.

Less likely to help

Patients with cervical cancer who are not receiving chemoradiation therapy may not benefit from this research.

What this research studies

This research focuses on improving outcomes for women with cervical cancer by identifying new radiation sensitizers that can enhance the effectiveness of chemoradiation therapy. Using a novel, non-invasive swab-based biopsy method, researchers will collect tissue samples before, during, and after treatment to analyze genetic changes associated with treatment response. The study aims to validate specific genetic mutations that may predict how well patients respond to therapy and to develop a platform for testing new targeted treatments based on these findings.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatment options for cervical cancer, potentially reducing relapse rates and improving survival outcomes.

How similar studies have gone: Previous research has shown promise in using genetic profiling to enhance cancer treatment, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Colbert, Lauren Elizabeth — University of Tx Md Anderson Can Ctr
  • Study coordinator: Colbert, Lauren Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.